Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Histocompatibility Testing × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3 Gynecologic 2 Gastrointestinal 2 Tumor-Agnostic 1 Other solid neoplasm 1 Head & Neck 1 Genitourinary 1 Dermatologic 1

Conditions

Interventions

pembrolizumab 26 Specimen Handling 18 Blood Specimen Collection 18 Magnetic Resonance Spectroscopy 17 Biopsy 16 Surveys and Questionnaires 12 atezolizumab 11 Bevacizumab 9 Radiosurgery 8 Paclitaxel 8 Fluorouracil 8 Standard of Care 7 Radiotherapy 7 Nivolumab 7 Irinotecan 7 Gemcitabine 7 Cisplatin 7 Carboplatin 7 durvalumab 6 Oxaliplatin 6 Leucovorin 6 Exercise 6 Cyclophosphamide 6 Capecitabine 6 olaparib 5 cabozantinib 5 alectinib 5 abemaciclib 5 Trastuzumab 5 Palliative Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04804878 2021-03-18

MSMTCC

Morehouse School of Medicine

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡